Scale, Cost, Quality: Enhancing Cell Therapy Development and Commercialization with Massively Parallelized Microfluidics

Learn how massively parallelized microfluidics can address cell therapy bottlenecks from discovery to commercialization. Key aspects that will be covered in this presentation by Astraveus:

• Microfluidic bioprocessors and their functional capabilities for cell processing and analytics ;
• Sample performance data of microfluidic bioprocessors ;
• Massively parallelized architecture for high-throughput optimization and parallelized manufacturing ;
• Overall impact on scale and COGS ;
• Partnership opportunities.